Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples